Maja Popović
Teaching Assistant
Oncology Institute of Vojvodina, Clinic for Internal Oncology
maja.popovic@mf.uns.ac.rs
Phone: 0214805500
ORCID ID : 0000-0002-1679-7144
Oncology Institute of Vojvodina, Clinic for Internal Oncology
maja.popovic@mf.uns.ac.rs
Phone: 0214805500
ORCID ID : 0000-0002-1679-7144
| Academic career | Year | Institution | Field |
|---|---|---|---|
Specialization |
2021 |
Faculty of Medicine Novi Sad |
Medical oncology | Status Acquired |
2019 |
Faculty of Medicine Novi Sad |
Oncology |
Graduated |
2012 |
Faculty of Medicine Novi Sad |
General medicine |
| M | Description |
|---|---|
51 | Popović M, Matovina-Brko G, Petrović D, Vranjković B, Radić J , Popović L. Prognostic value of age-adjusted international prognostic index in patients with relapsed or refractory diffuse large B-cell lymphoma- a single centre experience. Med Pregl 2019;LXXII (1-2): 25-29. |
34 | Matovina-Brko G, Popovic L, Popovic M. Immune-related adverse event, 10th French Serbian Oncology Congress, Novi Sad. 7-9 March 2019, p 35 |
51 | Vranković B, Petrović D, Radić J, Popović M, Kolarov Bjelobrk I, Petrović N. Optimal time for adjuvant therapy initiation in breast cancer patients: a single center experience. Med Pregl 2018; LXXI(11-12):394-403. |
34 | Susnjar S, Popovic L, Cvetanovic A, Stanic N, Citic J, Kolarov-Bjelobrk I et al. Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survival. Eur| J Cancer 2018;92(Suppl 3):S112(Abstr PB-024). |
34 | Popovic M, Matovina-Brko G, Popovic L, Vranjkovic B,Novel target and immunotherapy Options in the Treatment of NHL, 9th French Serbian Oncology Congress, Novi Sad. 16-17 march 2018, p 2-3. |
34 | Popovic L, Popovic M, Vranjkovic B, Matovina-Brko B. Renal Cell Carcinoma Treatment in 2018, 9th French Serbian Oncology Congress, Novi Sad. 16-17 march 2018, p 7. |
51 | Popovic LS, Matovina-Brko G, Popovic M. Checkpoint inhibitors in the treatment of urological malignancies. ESMO open 2017;2:e000165 |
23 | Matovina Brko G, Popovic M, Jovic M, Radic J, Bodlovic Kladar M, Nikolic I, Vidovic V, Kolarov Bjelobrk I, Kukic B, Salma S, Litavski J, Petrovic N, Vranjkovic B, Roganovic T, Ruzic M, Dugandzija T, Popovic L. COVID-19 vaccines and cancer patients: acceptance, attitudes and safety. J BUON. 2021 ;26(5):2183-2190. |
51 | Popovic M, Matovina-Brko G, Jovic M, Popovic LS. Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma. World J Clin Oncol. 2022 Jan 24;13(1):28-38. |
22 | Popovic LS, Matovina-Brko G, Popovic M, Popovic M, Cvetanovic A, Nikolic I, Kukic B, Petrovic D. Immunotherapy in the treatment of lymphoma. World J Stem Cells. 2021 Jun 26;13(6):503-520. |
| Course | Studies |
|---|---|
Oncology | Integrated academic studies in medicine |
Nursing care of oncology patient with basics of oncology | Undergraduate academic and applied studies in nursing |
Oncology and basic radiotherapy | Undergraduate applied studies in radiologic technology |
Special radiotherapy | Undergraduate applied studies in radiologic technology |